unknown
Stage
3
Investors
About
AlphaRose Therapeutics develops and commercializes genetic medicines for rare pediatric diseases, aiming to scale treatments for children suffering from genetic conditions with few existing therapies.
Explore AlphaRose Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.